The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFIRINOX de-escalation in advanced pancreatic cancer (aPC): A multicenter real-life study.
 
Hortense Chevalier
No Relationships to Disclose
 
Angélique Vienot
No Relationships to Disclose
 
Astrid Lièvre
No Relationships to Disclose
 
Julien Edeline
No Relationships to Disclose
 
Farid El Hajbi
No Relationships to Disclose
 
Charlotte Peugniez
No Relationships to Disclose
 
Dewi Vernerey
No Relationships to Disclose
 
Aurelia Meurisse
No Relationships to Disclose
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; ERYTECH Pharma (Inst); Halozyme; Mylan; Rafael Pharmaceuticals; VECT-HORUS
Speakers' Bureau - AstraZeneca; Celgene; ERYTECH Pharma; SERVIER; Shire
Research Funding - AstraZeneca (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Halozyme; Ipsen; Pfizer/EMD Serono; Shire; Vect-Horus
 
Cindy Neuzillet
No Relationships to Disclose
 
Christophe Borg
No Relationships to Disclose
 
Anthony Turpin
Honoraria - Amgen; Merck; SERVIER
Travel, Accommodations, Expenses - Pfizer; Sanofi